Pages that link to "Q81279975"
Jump to navigation
Jump to search
The following pages link to Protective conditioning for acute graft-versus-host disease (Q81279975):
Displaying 50 items.
- Defining the intensity of conditioning regimens: working definitions (Q24630836) (← links)
- NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment (Q26765845) (← links)
- New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity (Q26823090) (← links)
- The immunoregulatory role of type I and type II NKT cells in cancer and other diseases (Q27027556) (← links)
- Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments (Q28067102) (← links)
- High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment (Q31043227) (← links)
- Thymoglobulin--new approaches to optimal outcomes. (Q33388015) (← links)
- Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing (Q33531727) (← links)
- Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment (Q33556957) (← links)
- Current and future approaches for control of graft-versus-host disease (Q33642625) (← links)
- Path to clinical transplantation tolerance and prevention of graft-versus-host disease (Q33734003) (← links)
- Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen (Q33901277) (← links)
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit all (Q33917170) (← links)
- Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia (Q34109670) (← links)
- Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells (Q34221820) (← links)
- Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity (Q34429040) (← links)
- Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice. (Q34511576) (← links)
- Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond (Q34616147) (← links)
- Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG). (Q35032324) (← links)
- Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. (Q35095722) (← links)
- Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects (Q35127172) (← links)
- Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms (Q35317371) (← links)
- Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality (Q35662003) (← links)
- Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT. (Q35800814) (← links)
- Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile (Q35811893) (← links)
- Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism (Q35866143) (← links)
- The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation. (Q35874039) (← links)
- Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants (Q35918706) (← links)
- Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence (Q36057911) (← links)
- Pathophysiology of acute graft-versus-host disease: recent advances (Q36156559) (← links)
- Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies (Q36256781) (← links)
- Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning (Q36426327) (← links)
- Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes (Q36427007) (← links)
- Prevention of graft-vs.-host disease (Q36431047) (← links)
- Regulatory T Cell Immunotherapy in Immune-Mediated Diseases (Q36462109) (← links)
- Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs (Q36478455) (← links)
- In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease (Q36488762) (← links)
- Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro (Q36508920) (← links)
- Favorable preliminary results using TLI/ATG-based immunomodulatory conditioning for matched unrelated donor allogeneic hematopoietic stem cell transplantation in pediatric severe aplastic anemia. (Q36514033) (← links)
- Total lymphoid irradiation based conditioning for hematopoietic stem cell transplantation in severe aplastic anemia (Q36537051) (← links)
- Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct (Q36548370) (← links)
- Optimization of allogeneic transplant conditioning: not the time for dogma (Q36556498) (← links)
- A role for natural killer T cells in asthma (Q36636149) (← links)
- Low non-relapse mortality and long-term preserved quality of life in older patients undergoing matched related donor allogeneic stem cell transplantation: a prospective multicenter phase II trial (Q36715911) (← links)
- Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants (Q36727857) (← links)
- Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation (Q36761521) (← links)
- Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy (Q36779768) (← links)
- Graft-versus-host disease (Q36793622) (← links)
- Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin (Q36838087) (← links)
- Experimental and clinical approaches for optimization of the graft-versus-leukemia effect. (Q36863475) (← links)